P4. Autologous blood coagulum as a native carrier for rhBMP6 induces new bone formation and posterolateral lumbar spine fusion in rabbits and sheep
Munish C. Gupta, MD1; Lovorka Grgurevic, MD, PhD2; Marko Pecin, PhD3; Igor Erjavec, PhD4; Marija Lipar, PhD5; Jadranka Bubić, DVM, PhD4; Drazen Maticic, PhD, MSc3; Drazen Vnuk, PhD3; Kuber T. Sampath, PhD6; Slobodan Vukičević, MD, PhD4
1Washington University School of Medicine, St. Louis, MO, US; 2Medical School University of Zagreb, Zagreb, Croatia; 3School of Veterinary Medicine, Zagreb, Zagreb, Croatia; 4School of Medicine, University of Zagreb, Zagreb, Croatia; 5Faculty of Veterinary Medicine University of Zagreb, Zagreb, Croatia; 6perForm Biologics Inc, Holliston, MA, US
FDA DEVICE/DRUG STATUS: RhBMP6 (Not approved for this indication)
P1. Improvement of motor function induced by skeletal muscle contraction in spinal cord injury rats
Norito Hayashi, MD1; Naoyuki Himi, PhD1; Emi Nakamura-Maruyama, PhD1; Naohiko Okabe, PhD, DVM2; Issei Sakamoto, MD1; Toru Hasegawa, MD, PhD1; Osamu Miyamoto, MD, PhD1
1Kawasaki Medical School Hospital, Matushima Kurashiki, Okayama, Japan; 2Second Department of Physiology, Kawasaki Medical School, Kurashiki City, Okayama, Japan
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.